Delivery Order SPE2DB22D3501-SPE2DB25FXK82
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,113.35 for 100 tablets of Dexamethasone 4 mg, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, employs firm fixed-price pricing and involves no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Dexamethasone 120 mg/30 ml vials with a ceiling value of $1,050.40. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dexamethasone 4 mg tablets in unit dose packaging of 100 tablets. This firm fixed-price delivery order, valued at $1,424.94, is scheduled for completion by September 22, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,242.49 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Dexamethasone 4 mg tablets in unit-dose packages of 100 units. This is a non-set-aside competitive award with an ultimate completion date of July 1, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dexamethasone 10 mg/ml vials with a ceiling value of $1,171.69. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The work is to be completed by September 18, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,824.44 on August 13, 2025, to supply Dexamethasone 10mg/ml in vials (25-count units) to the Defense Logistics Agency's Medical Supply Chain. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 10, 2025. The delivery order represents work performed under AmerisourceBergen's larger Indefinite...
- This is a $1,046.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,883,375 units of dexamethasone 4 mg tablets. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- The Defense Logistics Agency awarded a delivery order valued at $2,671.80 to AmerisourceBergen Drug Corp for Dexamethasone 4 mg tablets in unit dose packages of 100 units. This firm fixed price, non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used across military and federal...
- The Defense Logistics Agency awarded a $4,707.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexamethasone 20 mg/5 mL vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency awarded a $2,466.91 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dexamethasone 20 mg/5 mL vials. This firm fixed-price, competitively awarded contract—with no set-aside designation—is scheduled for completion by September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dexamethasone is a corticosteroid medication commonly used in military and federal healthcare...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK82Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 19, 2025, for the supply of Dexamethasone 4 mg tablets (100 count) with a ceiling value of $1,865.16. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, will be performed at the contractor's Conshohocken facility. The award was made without a set-aside designation, indicating AmerisourceBergen competed in an open procurement process. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical supply agreement serves as a global vehicle enabling the contractor to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal medical systems worldwide. The current delivery order represents a routine procurement of a corticosteroid medication commonly used in military and veteran healthcare settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/19/25 |